Cargando…

X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy

X-linked dilated cardiomyopathy (XLDCM) is a distinct phenotype of dystrophinopathy characterized by preferential cardiac involvement without any overt skeletal myopathy. XLDCM is caused by mutations of the Duchenne muscular dystrophy (DMD) gene and results in lethal heart failure in individuals bet...

Descripción completa

Detalles Bibliográficos
Autor principal:	Nakamura, Akinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491663/ https://www.ncbi.nlm.nih.gov/pubmed/26066469 http://dx.doi.org/10.3390/ph8020303

Ejemplares similares

Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy
por: Müntze, Jonas, et al.
Publicado: (2018)

Proteomic Profiling of the Dystrophin-Deficient mdx Phenocopy of Dystrophinopathy-Associated Cardiomyopathy
por: Holland, Ashling, et al.
Publicado: (2014)

MicroRNAs in Dystrophinopathy
por: Lee, Ahyoung, et al.
Publicado: (2022)

Advances in Dystrophinopathy Diagnosis and Therapy
por: Saad, Fawzy A., et al.
Publicado: (2023)

Late-Onset Dystrophinopathy
por: Singh, Ranjan K
Publicado: (2021)

Genotypes and Phenotypes of DMD Small Mutations in Chinese Patients With Dystrophinopathies
por: Wang, Liang, et al.
Publicado: (2019)

Modern View on the Role of Sex-Specific Levels of High-Sensitive Cardiospecific Troponins T and I in the Diagnosis of Myocardial Infarction
por: Chaulin, Aleksey
Publicado: (2023)

Metabolic Pathway of Cardiospecific Troponins: From Fundamental Aspects to Diagnostic Role (Comprehensive Review)
por: Chaulin, Aleksey M.
Publicado: (2022)

Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
por: Juan-Mateu, Jonàs, et al.
Publicado: (2012)

Involvement of adiponectin in the pathogenesis of dystrophinopathy
por: Abou-Samra, Michel, et al.
Publicado: (2015)

Reassessing carrier status for dystrophinopathies
por: Newcomb, Tara M., et al.
Publicado: (2016)

Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy Phenotypes
por: Juan-Mateu, Jonàs, et al.
Publicado: (2013)

Dystrophinopathy Phenotypes and Modifying Factors in DMD Exon 45–55 Deletion
por: Poyatos‐García, Javier, et al.
Publicado: (2022)

Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan
por: Okubo, Mariko, et al.
Publicado: (2017)

Dilated cardiomyopathy and aldosteronoma: a causal link?
por: Zhang, Jiyu, et al.
Publicado: (2019)

Rare Presentation of β-Thalassemia Intermedia With a Phenotype of Dilated Cardiomyopathy
por: Nakaya, Yuichiro, et al.
Publicado: (2023)

Clinical and Genetic Characterization of Female Dystrophinopathy
por: Lee, Seung Ha, et al.
Publicado: (2015)

Hypertension as One of the Main Non-Myocardial Infarction-Related Causes of Increased Cardiospecific Troponins: From Mechanisms to Significance in Current Medical Practice
por: Chaulin, Aleksey Michailovich
Publicado: (2022)

Comprehensive genetic characteristics of dystrophinopathies in China
por: Ma, Peipei, et al.
Publicado: (2018)

Efficacy and safety of hydrokinesitherapy in patients with dystrophinopathy
por: Suslov, V. M., et al.
Publicado: (2023)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations
por: Juan-Mateu, Jonas, et al.
Publicado: (2015)

Obesity modifies the energetic phenotype of dilated cardiomyopathy
por: Rayner, Jennifer J, et al.
Publicado: (2021)

Ataluren treatment of patients with nonsense mutation dystrophinopathy
por: Bushby, Katharine, et al.
Publicado: (2014)

Clinical and genetic characteristics of female dystrophinopathy carriers
por: Zhong, Jingzi, et al.
Publicado: (2019)

Molecular Diagnosis in 100% of Dystrophinopathies: Are We There Yet?
por: Pegoraro, Elena
Publicado: (2021)

Correction to: Comprehensive genetic characteristics of dystrophinopathies in China
por: Ma, Peipei, et al.
Publicado: (2021)

A case report: X-linked dystrophin gene mutation causing severe isolated dilated cardiomyopathy
por: Lester, Geoffrey, et al.
Publicado: (2019)

Wechsler Scale Intelligence Testing in Males with Dystrophinopathies: A Review and Meta-Analysis
por: Weerkamp, Pien M. M., et al.
Publicado: (2022)

Echocardiographic Advances in Dilated Cardiomyopathy
por: Faggiano, Andrea, et al.
Publicado: (2021)

Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
por: Tayal, Upasana, et al.
Publicado: (2022)

Cardiospecific Overexpression of ATPGD1 (Carnosine Synthase) Increases Histidine Dipeptide Levels and Prevents Myocardial Ischemia Reperfusion Injury
por: Zhao, Jingjing, et al.
Publicado: (2020)

Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies
por: Lim, Kenji Rowel Q., et al.
Publicado: (2020)

A case of pregnancy complicated with dilated cardiomyopathy 1X
por: Oki, Shinya, et al.
Publicado: (2015)

The Mutations Associated with Dilated Cardiomyopathy
por: Parvari, Ruti, et al.
Publicado: (2012)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Titin: a phenotype-genotype descriptive comparison of dilated cardiomyopathy
por: Baksi, Arun J, et al.
Publicado: (2014)

Dystrophin Genotype and Risk of Neuropsychiatric Disorders in Dystrophinopathies: A Systematic Review and Meta-Analysis
por: Pascual-Morena, Carlos, et al.
Publicado: (2023)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Study of Dystrophinopathy in Eastern Uttar Pradesh Population of India
por: Kumari, Preeti, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aird7p6l2o4ha53rmrp8ug52b3